Compile Data Set for Download or QSAR
Found 173 Enz. Inhib. hit(s) with Target = 'Interleukin-6'
TargetInterleukin-6 receptor subunit alpha(Rattus norvegicus)
Solvay Duphar B.V.

Curated by ChEMBL
LigandPNGBDBM85330(CAS_68647 | NSC_68647 | ONDANSETRON | Ondansetron ...)copy SMILEScopy InChI
Affinity DataKi: >1.00E+4nMAssay Description:The binding affinity of the compound was measured on leukotriene-6 receptor using [3H]- IL-6 as radioligand.More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NS0SZHPubMed
TargetInterleukin-6 receptor subunit alpha(Rattus norvegicus)
Solvay Duphar B.V.

Curated by ChEMBL
LigandPNGBDBM50231569(Cilansetron | KC-9946)copy SMILEScopy InChI
Affinity DataKi: >1.00E+4nMAssay Description:The binding affinity was measured on leukotriene-6 receptor using [3H]- IL-6 as radioligand.More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2NS0SZHPubMed
TargetInterleukin-6(Homo sapiens (Human))
SANTEN PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM414420((R)-7-[4-(2-ethoxycarbonyl-2-hydroxyethyl)oxy-2-me...)copy SMILEScopy InChI
Affinity DataIC50: 1nMAssay Description:1) The subcultured HCE-T was recovered and the cells were seeded at 2.0×104 cells/0.1 mL/well in a 96-well flat bottom culture plate.2) After culturi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2X350TPUS Patent
TargetInterleukin-6(Homo sapiens (Human))
SANTEN PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM331838((R)-7-[4-(2-ethoxycarbonyl-2-hydroxyethyl)oxy-2-me...)copy SMILEScopy InChI
Affinity DataIC50: 1nMAssay Description:o evaluate the action of the present compounds as a GR agonist, IL-6 production inhibitory action in human corneal epithelial cell line after LPS sti...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q21G0PBHUS Patent
TargetInterleukin-6(Homo sapiens (Human))
SANTEN PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM140015(US8901310, Comparator E)copy SMILEScopy InChI
Affinity DataIC50: 1.10nMAssay Description:The glucocorticoid receptor fluorescence polarization ligand binding (GRFP) assay is used to evaluate direct binding of testing compounds to full-len...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2MC8XQMUS Patent
TargetInterleukin-6(Homo sapiens (Human))
SANTEN PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM140013(US8901310, Comparator C)copy SMILEScopy InChI
Affinity DataIC50: 1.10nMAssay Description:The glucocorticoid receptor fluorescence polarization ligand binding (GRFP) assay is used to evaluate direct binding of testing compounds to full-len...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2MC8XQMUS Patent
TargetInterleukin-6(Homo sapiens (Human))
SANTEN PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM140014(US8901310, Comparator D)copy SMILEScopy InChI
Affinity DataIC50: 1.30nMAssay Description:The glucocorticoid receptor fluorescence polarization ligand binding (GRFP) assay is used to evaluate direct binding of testing compounds to full-len...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2MC8XQMUS Patent
TargetInterleukin-6(Homo sapiens (Human))
SANTEN PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM140017(US8901310, Comparator G)copy SMILEScopy InChI
Affinity DataIC50: 2.10nMAssay Description:The glucocorticoid receptor fluorescence polarization ligand binding (GRFP) assay is used to evaluate direct binding of testing compounds to full-len...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2MC8XQMUS Patent
TargetInterleukin-6(Homo sapiens (Human))
SANTEN PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM140019(US8901310, Comparator I)copy SMILEScopy InChI
Affinity DataIC50: 2.80nMAssay Description:The glucocorticoid receptor fluorescence polarization ligand binding (GRFP) assay is used to evaluate direct binding of testing compounds to full-len...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2MC8XQMUS Patent
TargetInterleukin-6(Homo sapiens (Human))
SANTEN PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM65497(CC-220 (Compound 6) | US9694015, 6.4S)copy SMILEScopy InChI
Affinity DataIC50: 3.80nMT: 2°CAssay Description:The Fix buffer I was warmed up to 37° C. in an incubator or water bath prior to use. The Perm Buffer III was chilled in a â¿¿20° C. freezer p...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2R49NZNUS Patent
TargetInterleukin-6(Homo sapiens (Human))
SANTEN PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM140012(US8901310, Comparator B)copy SMILEScopy InChI
Affinity DataIC50: 4nMAssay Description:The glucocorticoid receptor fluorescence polarization ligand binding (GRFP) assay is used to evaluate direct binding of testing compounds to full-len...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2MC8XQMUS Patent
TargetInterleukin-6(Homo sapiens (Human))
SANTEN PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM19190((1S,2R,10S,11S,14R,15S,17S)-14,17-dihydroxy-14-(2-...)copy SMILEScopy InChI
Affinity DataIC50: 4.20nMAssay Description:The glucocorticoid receptor fluorescence polarization ligand binding (GRFP) assay is used to evaluate direct binding of testing compounds to full-len...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2MC8XQMUS Patent
TargetInterleukin-6(Homo sapiens (Human))
SANTEN PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM140018(US8901310, Comparator H)copy SMILEScopy InChI
Affinity DataIC50: 4.30nMAssay Description:The glucocorticoid receptor fluorescence polarization ligand binding (GRFP) assay is used to evaluate direct binding of testing compounds to full-len...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2MC8XQMUS Patent
TargetInterleukin-6(Homo sapiens (Human))
SANTEN PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM140016(US8901310, Comparator F)copy SMILEScopy InChI
Affinity DataIC50: 7nMAssay Description:The glucocorticoid receptor fluorescence polarization ligand binding (GRFP) assay is used to evaluate direct binding of testing compounds to full-len...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2MC8XQMUS Patent
TargetInterleukin-6(Homo sapiens (Human))
SANTEN PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM77001(3-(4-((4-(morpholinomethyl)benzyl)-oxy)-1-oxoisoin...)copy SMILEScopy InChI
Affinity DataIC50: 10nMT: 2°CAssay Description:The Fix buffer I was warmed up to 37° C. in an incubator or water bath prior to use. The Perm Buffer III was chilled in a â¿¿20° C. freezer p...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2R49NZNUS Patent
TargetInterleukin-6(Homo sapiens (Human))
SANTEN PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM331841((S)-7-[4-(3-cyano-2-hydroxypropyl)oxy-2-methoxyphe...)copy SMILEScopy InChI
Affinity DataIC50: 13nMAssay Description:1) The subcultured HCE-T was recovered and the cells were seeded at 2.0×104 cells/0.1 mL/well in a 96-well flat bottom culture plate.2) After culturi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2X350TPUS Patent
TargetInterleukin-6(Homo sapiens (Human))
SANTEN PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM331841((S)-7-[4-(3-cyano-2-hydroxypropyl)oxy-2-methoxyphe...)copy SMILEScopy InChI
Affinity DataIC50: 13nMAssay Description:o evaluate the action of the present compounds as a GR agonist, IL-6 production inhibitory action in human corneal epithelial cell line after LPS sti...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q21G0PBHUS Patent
TargetInterleukin-6(Homo sapiens (Human))
SANTEN PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM331840((R)-7-[4-(3-cyano-2-hydroxypropyl)oxy-2-methoxyphe...)copy SMILEScopy InChI
Affinity DataIC50: 14nMAssay Description:o evaluate the action of the present compounds as a GR agonist, IL-6 production inhibitory action in human corneal epithelial cell line after LPS sti...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q21G0PBHUS Patent
TargetInterleukin-6(Homo sapiens (Human))
SANTEN PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM331840((R)-7-[4-(3-cyano-2-hydroxypropyl)oxy-2-methoxyphe...)copy SMILEScopy InChI
Affinity DataIC50: 14nMAssay Description:1) The subcultured HCE-T was recovered and the cells were seeded at 2.0×104 cells/0.1 mL/well in a 96-well flat bottom culture plate.2) After culturi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2X350TPUS Patent
TargetInterleukin-6(Homo sapiens (Human))
SANTEN PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM331839((S)-7-[4-(2,4-dihydroxybutyl)oxy-2-methoxyphenyl]-...)copy SMILEScopy InChI
Affinity DataIC50: 15nMAssay Description:1) The subcultured HCE-T was recovered and the cells were seeded at 2.0×104 cells/0.1 mL/well in a 96-well flat bottom culture plate.2) After culturi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2X350TPUS Patent
TargetInterleukin-6(Homo sapiens (Human))
SANTEN PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM331839((S)-7-[4-(2,4-dihydroxybutyl)oxy-2-methoxyphenyl]-...)copy SMILEScopy InChI
Affinity DataIC50: 15nMAssay Description:o evaluate the action of the present compounds as a GR agonist, IL-6 production inhibitory action in human corneal epithelial cell line after LPS sti...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q21G0PBHUS Patent
TargetInterleukin-6(Homo sapiens (Human))
SANTEN PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM331836((S)-8-(5-fluoro-2-methylphenoxymethyl)-7-[4-(2-hyd...)copy SMILEScopy InChI
Affinity DataIC50: 33nMAssay Description:1) The subcultured HCE-T was recovered and the cells were seeded at 2.0×104 cells/0.1 mL/well in a 96-well flat bottom culture plate.2) After culturi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2X350TPUS Patent
TargetInterleukin-6(Homo sapiens (Human))
SANTEN PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM331836((S)-8-(5-fluoro-2-methylphenoxymethyl)-7-[4-(2-hyd...)copy SMILEScopy InChI
Affinity DataIC50: 33nMAssay Description:o evaluate the action of the present compounds as a GR agonist, IL-6 production inhibitory action in human corneal epithelial cell line after LPS sti...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q21G0PBHUS Patent
TargetInterleukin-6(Homo sapiens (Human))
SANTEN PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM331837((R)-8-(5-fluoro-2-methylphenoxymethyl)-7-[4-(2-hyd...)copy SMILEScopy InChI
Affinity DataIC50: 34nMAssay Description:o evaluate the action of the present compounds as a GR agonist, IL-6 production inhibitory action in human corneal epithelial cell line after LPS sti...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q21G0PBHUS Patent
TargetInterleukin-6(Homo sapiens (Human))
SANTEN PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM331837((R)-8-(5-fluoro-2-methylphenoxymethyl)-7-[4-(2-hyd...)copy SMILEScopy InChI
Affinity DataIC50: 34nMAssay Description:1) The subcultured HCE-T was recovered and the cells were seeded at 2.0×104 cells/0.1 mL/well in a 96-well flat bottom culture plate.2) After culturi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2X350TPUS Patent
TargetInterleukin-6(Homo sapiens (Human))
SANTEN PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM140011(US8901310, Comparator A)copy SMILEScopy InChI
Affinity DataIC50: 36.4nMAssay Description:The glucocorticoid receptor fluorescence polarization ligand binding (GRFP) assay is used to evaluate direct binding of testing compounds to full-len...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2MC8XQMUS Patent
TargetInterleukin-6(Homo sapiens (Human))
SANTEN PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM65456(19171-19-8 | 4-amino-2-(2,6-dioxopiperidin-3-yl)is...)copy SMILEScopy InChI
Affinity DataIC50: 59nMT: 2°CAssay Description:The Fix buffer I was warmed up to 37° C. in an incubator or water bath prior to use. The Perm Buffer III was chilled in a â¿¿20° C. freezer p...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2R49NZNUS Patent
TargetInterleukin-6(Homo sapiens (Human))
SANTEN PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM76986(3-(5-amino-2-methyl-4-oxo-4H-quinazolin-3-yl)-pipe...)copy SMILEScopy InChI
Affinity DataIC50: 60nMT: 2°CAssay Description:The Fix buffer I was warmed up to 37° C. in an incubator or water bath prior to use. The Perm Buffer III was chilled in a â¿¿20° C. freezer p...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2R49NZNUS Patent
TargetInterleukin-6(Homo sapiens (Human))
SANTEN PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM140010(US8901310, Example 2)copy SMILEScopy InChI
Affinity DataIC50: 60nMAssay Description:The glucocorticoid receptor fluorescence polarization ligand binding (GRFP) assay is used to evaluate direct binding of testing compounds to full-len...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2MC8XQMUS Patent
TargetInterleukin-6(Homo sapiens (Human))
SANTEN PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM77015((R)-3-(4-((4-(morpholinomethyl)benzyl)-oxy)-1-oxoi...)copy SMILEScopy InChI
Affinity DataIC50: 83nMT: 2°CAssay Description:The Fix buffer I was warmed up to 37° C. in an incubator or water bath prior to use. The Perm Buffer III was chilled in a â¿¿20° C. freezer p...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2R49NZNUS Patent
TargetInterleukin-6(Homo sapiens (Human))
SANTEN PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM331842(7-[4-(3-t-butoxycarbonyl-2-hydroxypropyl)oxy-2-met...)copy SMILEScopy InChI
Affinity DataIC50: 83nMAssay Description:1) The subcultured HCE-T was recovered and the cells were seeded at 2.0×104 cells/0.1 mL/well in a 96-well flat bottom culture plate.2) After culturi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2X350TPUS Patent
TargetInterleukin-6(Homo sapiens (Human))
SANTEN PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM331842(7-[4-(3-t-butoxycarbonyl-2-hydroxypropyl)oxy-2-met...)copy SMILEScopy InChI
Affinity DataIC50: 83nMAssay Description:o evaluate the action of the present compounds as a GR agonist, IL-6 production inhibitory action in human corneal epithelial cell line after LPS sti...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q21G0PBHUS Patent
TargetInterleukin-6(Homo sapiens (Human))
SANTEN PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM331844(8-(5-fluoro-2-methylphenoxymethyl)-7-(5-hydroxy-2-...)copy SMILEScopy InChI
Affinity DataIC50: 93nMAssay Description:1) The subcultured HCE-T was recovered and the cells were seeded at 2.0×104 cells/0.1 mL/well in a 96-well flat bottom culture plate.2) After culturi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2X350TPUS Patent
TargetInterleukin-6(Homo sapiens (Human))
SANTEN PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM331844(8-(5-fluoro-2-methylphenoxymethyl)-7-(5-hydroxy-2-...)copy SMILEScopy InChI
Affinity DataIC50: 93nMAssay Description:o evaluate the action of the present compounds as a GR agonist, IL-6 production inhibitory action in human corneal epithelial cell line after LPS sti...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q21G0PBHUS Patent
TargetInterleukin-6(Homo sapiens (Human))
SANTEN PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM331843(8-(5-fluoro-2-methylphenoxymethyl)-7-(5-hydroxymet...)copy SMILEScopy InChI
Affinity DataIC50: 123nMAssay Description:o evaluate the action of the present compounds as a GR agonist, IL-6 production inhibitory action in human corneal epithelial cell line after LPS sti...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q21G0PBHUS Patent
TargetInterleukin-6(Homo sapiens (Human))
SANTEN PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM331843(8-(5-fluoro-2-methylphenoxymethyl)-7-(5-hydroxymet...)copy SMILEScopy InChI
Affinity DataIC50: 123nMAssay Description:1) The subcultured HCE-T was recovered and the cells were seeded at 2.0×104 cells/0.1 mL/well in a 96-well flat bottom culture plate.2) After culturi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2X350TPUS Patent
TargetInterleukin-6(Homo sapiens (Human))
SANTEN PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM50349518(BERGENIN)copy SMILEScopy InChI
Affinity DataIC50: 208nMAssay Description:Inhibition of IL6 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q20004JFPubMed
TargetInterleukin-6(Homo sapiens (Human))
SANTEN PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM140020(US8901310, Comparator J)copy SMILEScopy InChI
Affinity DataIC50: 291nMAssay Description:The glucocorticoid receptor fluorescence polarization ligand binding (GRFP) assay is used to evaluate direct binding of testing compounds to full-len...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2MC8XQMUS Patent
TargetInterleukin-6(Homo sapiens (Human))
SANTEN PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM50487989(CHEMBL5282465)copy SMILEScopy InChI
Affinity DataIC50: 560nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
TargetInterleukin-6(Homo sapiens (Human))
SANTEN PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM50487988(CHEMBL5289737)copy SMILEScopy InChI
Affinity DataIC50: 600nMMore data for this Ligand-Target Pair
In DepthDetails
TargetInterleukin-6(Homo sapiens (Human))
SANTEN PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM50487987(CHEMBL2391027)copy SMILEScopy InChI
Affinity DataIC50: 860nMMore data for this Ligand-Target Pair
In DepthDetails
TargetInterleukin-6(Homo sapiens (Human))
SANTEN PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM65454(191732-72-6 | CC-5013 | Lenalidomide | Revimid | R...)copy SMILEScopy InChI
Affinity DataIC50: 1.20E+3nMT: 2°CAssay Description:The Fix buffer I was warmed up to 37° C. in an incubator or water bath prior to use. The Perm Buffer III was chilled in a â¿¿20° C. freezer p...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2R49NZNUS Patent
TargetInterleukin-6(Homo sapiens (Human))
SANTEN PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM50486736(CHEMBL5285518)copy SMILEScopy InChI
Affinity DataIC50: 1.28E+3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
TargetInterleukin-6 receptor subunit beta(Homo sapiens (Human))
Dongguk University-Seoul

Curated by ChEMBL
LigandPNGBDBM50145177(CHEMBL3764956)copy SMILEScopy InChI
Affinity DataIC50: 1.48E+3nMAssay Description:Inhibition of CDK2/Cyclin E (unknown origin) expressed in baculoviral infected insect Sf9 cells using histone H1 as substrate in presence of [gamma-3...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XD13JXPubMed
TargetInterleukin-6(Homo sapiens (Human))
SANTEN PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM50487031(CHEMBL5287859)copy SMILEScopy InChI
Affinity DataIC50: 1.63E+3nMMore data for this Ligand-Target Pair
In DepthDetails
TargetInterleukin-6(Homo sapiens (Human))
SANTEN PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM50486737(CHEMBL5268975)copy SMILEScopy InChI
Affinity DataIC50: 2.00E+3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
TargetInterleukin-6(Homo sapiens (Human))
SANTEN PHARMACEUTICAL CO., LTD.

US Patent
LigandPNGBDBM50252381(CHEMBL4080826)copy SMILEScopy InChI
Affinity DataIC50: 5.80E+3nMAssay Description:Inhibition of IL-6 signaling pathway in human HepG2 cells transfected with p-STAT3-Luc assessed as reduction in IL-6 induced STAT3 phosphorylation pr...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2KW5JF6PubMed
TargetInterleukin-6 receptor subunit beta(Homo sapiens (Human))
Dongguk University-Seoul

Curated by ChEMBL
LigandPNGBDBM50145193(CHEMBL3765505)copy SMILEScopy InChI
Affinity DataIC50: 5.90E+3nMAssay Description:Inhibition of CDK2/Cyclin E (unknown origin) expressed in baculoviral infected insect Sf9 cells using histone H1 as substrate in presence of [gamma-3...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XD13JXPubMed
TargetInterleukin-6 receptor subunit beta(Homo sapiens (Human))
Dongguk University-Seoul

Curated by ChEMBL
LigandPNGBDBM50145178(CHEMBL3764721)copy SMILEScopy InChI
Affinity DataIC50: 6.38E+3nMAssay Description:Inhibition of CDK2/Cyclin E (unknown origin) expressed in baculoviral infected insect Sf9 cells using histone H1 as substrate in presence of [gamma-3...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XD13JXPubMed
TargetInterleukin-6 receptor subunit beta(Homo sapiens (Human))
Dongguk University-Seoul

Curated by ChEMBL
LigandPNGBDBM50145189(CHEMBL3764217)copy SMILEScopy InChI
Affinity DataIC50: 6.55E+3nMAssay Description:Inhibition of CDK2/Cyclin E (unknown origin) expressed in baculoviral infected insect Sf9 cells using histone H1 as substrate in presence of [gamma-3...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XD13JXPubMed
Displayed 1 to 50 (of 173 total ) | Next | Last >>
Jump to: